Khalid AlSaleh

2PUBLICATIONS
19CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 21, 2022
An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction.

İrfan Cicin, Mohammed Oukkal, Hassen Mahfouf

|Jun 04, 2021
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.

Khalid AlSaleh, Heba Al Zahwahry, Adda Bounedjar

Pageof 1

Frequent Collaborators

2 joint publications

Mohammed Oukkal

1 joint publications

Assia Bensalem

1 joint publications

Hikmat Abdel-Razeq

1 joint publications

Alaa Kandil